Check out our highly characterized donor pool that allows researchers to select specific donors

HemaCare donor center is FDA-registered and AABB-compliant, view our accreditations

Rigorous operational controls and quality systems for cell processing and preservation

Join our donor program and contribute to life-changing research!

Cell Tissues

Human hematopoietic stem cells and blood derived cell products are HemaCare’s specialty. We focus on peripheral blood, bone marrow, cord blood and mobilized peripheral blood so you can be assured you are getting the best blood products for your research.

See our tissues

Cell Types

HemaCare’s portfolio offers isolated hematopoietic cells from both the lymphoid production path and the myeloid lineage. Many are offered as either positive or negative selection using best in class immunomagnetic separation technology with our own proprietary protocols.

See our cell types

Disease State

If you need disease state whole blood, serum, plasma or mononuclear cells, HemaCare is your source!HemaCare’s portfolio includes infectious diseases, solid tumor and hematopoietic cancers, and autoimmune samples to further your research. If you can’t find what you are looking for, contact us!

See our disease states

Cell Therapy

Cell Therapy

From bench to bedside – we are committed to cell therapy and your success!

Apheresis collection is our specialty and, building on over 38 years of experience, we have optimized cell collection by controlling and qualifying our apheresis procedures and collection sites, bringing a higher degree of reproducibility to research projects or manufacturing efforts based on cGMP and cGTP principles.  Our extensive global portfolio of support services span non-clinical studies, clinical trials, and commercial product manufacturing, providing complementary resources and expertise to enhance your studies.

  • Cell isolation (positive or negative selection)
  • Cryopreservation and storage
  • Thawing and preparing cells
  • Testing cell viability
  • Flow cytometric analysis
  • Serological testing

Learn more…

Our Latest News

HemaCare To Present At Phacilitate Cell & Gene Therapy World 2016

LOS ANGELES – Jan. 11, 2016 – HemaCare Corporation, a leader in cell and tissue collection, processing and cell therapy solutions, today announced that Lou Juliano, Senior Vice President of Global Sales and Business Development, will present recent findings by HemaCare’s research group on the sustainability of freshly isolated leukopaks (apheresis-derived white blood cells) when cryopreserved […]

HemaCare Signs Strategic Global Distribution Agreements

LOS ANGELES, CA, December 7, 2015 – HemaCare Corporation, a leader in cell and tissue collection, processing, and autologous and allogeneic cell therapy solutions, has expanded its global capabilities through strategic distribution agreements in North America, Europe and Asia. These partnerships ensure researchers around the globe can access HemaCare’s human healthy and disease state, fresh […]

HemaCare To Support Key Cell Therapy Conferences Through Sponsorship And Technical Presentations

LOS ANGELES, CA, November 2, 2015 – HemaCare Corporation, a leader in cell and tissue collection, processing and cell therapy solutions, will present at two of the most important meetings in cellular and immune-therapy this month. Each presentation will focus on HemaCare’s expertise in preserving hematopoietic cells for use by researchers and developers of immunotherapy. […]